German medical technology aids: competition for large contracts opened up:
This article was originally published in Clinica
The much-criticised provision of Germany's April 1 health financing reform/increased competition law on the tendering for medtech aids contracts was one of the key themes at industry association BVMed's May 23 conference on general medtech industry matters. Contracts over the value of Euro211, 000 ($290,000) must be opened up to competition in wider Europe, delegates at the Konigswinter session heard. Meeting moderator Michael Banz (of Paul Hartmann AG) renewed the plea that contracts that needed a high degree of customer service/follow-up be awarded to local providers.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.